Antibacterial drug shortages from 2001 to 2013: implications for clinical practice

scientific article published on 22 April 2015

Antibacterial drug shortages from 2001 to 2013: implications for clinical practice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/CID/CIV201
P698PubMed publication ID25908680

P50authorMark ZocchiQ95972029
Larissa S MayQ97526898
Kristy L HawleyQ117262466
Jesse M PinesQ86508774
Erin R. FoxQ91934153
Maryann Mazer-AmirshahiQ92116038
P2093author name stringFarha Quadri
P2860cites workEthical challenges: managing oncology drug shortagesQ36678216
Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now.Q37857510
Prospective approach to managing antimicrobial drug shortages.Q38016318
Disruptions in the supply of medications used in transplantation: implications and management strategies for the transplant clinicianQ38057787
The spread and acquisition of NDM-1: a multifactorial problemQ38168928
Deaths attributable to carbapenem-resistant Enterobacteriaceae infectionsQ38222776
Prioritized current unmet needs for antibacterial therapiesQ38233288
Perspectives and concerns regarding antimicrobial agent shortages among infectious disease specialistsQ42279326
Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011).Q46880435
Antimicrobial Drug Shortages: A Crisis Amidst the Epidemic and the Need for Antimicrobial Stewardship Efforts to Lessen the EffectsQ57779691
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectdrug shortageQ94443615
P304page(s)1737-1742
P577publication date2015-04-22
P1433published inClinical Infectious DiseasesQ5133764
P1476titleAntibacterial drug shortages from 2001 to 2013: implications for clinical practice
P478volume60

Reverse relations

cites work (P2860)
Q58699813A challenge for healthcare but just another opportunity for illegitimate online sellers: Dubious market of shortage oncology drugs
Q94955085ACMT Position Statement: Medication Shortages During Coronavirus Disease Pandemic
Q47742725Antibiotic Expenditures by Medication, Class, and Healthcare Setting in the United States, 2010-2015.
Q55003936Antimicrobial Agent Shortages: The New Norm for Infectious Diseases Physicians.
Q92157029Availability and Use of Therapeutic Interchange Policies in Managing Antimicrobial Shortages among South African Public Sector Hospitals; Findings and Implications
Q38893259Combating antibiotic resistance, mitigating future threats and ongoing initiatives.
Q60949339Combatting Antibiotic Resistance Together: How Can We Enlist the Help of Industry?
Q38603136Diabetic foot infections: Current treatment and delaying the 'post-antibiotic era'.
Q47117346Early Antimicrobial De-escalation and Stewardship in Adult Hematopoietic Stem Cell Transplantation Recipients: Retrospective Review
Q40423878Effective Antibiotic Conservation by Emergency Antimicrobial Stewardship During a Drug Shortage.
Q93335108Longitudinal trends in U.S. shortages of sterile solutions, 2001-17
Q26771470Minocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic Review
Q47651919Resensitization of methicillin-resistant Staphylococcus aureus by amoxapine, an FDA-approved antidepressant
Q26853271Reviving old antibiotics
Q59335056Sustainable Access to Antimicrobials; A Missing Component to Antimicrobial Stewardship-A Tale of Two Countries
Q90089596The French reporting system for drug shortages: description and trends from 2012 to 2018: an observational retrospective study
Q39259740The Impact of Shortages on Medication Prices: Implications for Shortage Prevention
Q38819361The effect of a piperacillin/tazobactam shortage on antimicrobial prescribing and Clostridium difficile risk in 88 U.S. medical centers.
Q44513902The unexpected benefits of the national piperacillin/tazobactam shortage on antibiotic stewardship
Q41987286Trends in pricing and generic competition within the oral antibiotic drug market in the United States.
Q41925961U.S. vaccine and immune globulin product shortages, 2001-15.
Q54265868Unavailability of old antibiotics threatens effective treatment for common bacterial infections.

Search more.